Two Charged in Ozempic Counterfeit Drug Scheme by DOJ
Published on Β· Source: cnbc.com

AI Summary
Summarized by AI from the source belowTwo Indian nationals, Swapnadip Roy and Vicky Ramancha, have been charged in Florida with smuggling counterfeit Ozempic from China. They face a maximum sentence of 71 years in prison if convicted. Allegations state that the smuggling scheme began in July 2023 and continued through April 2024. The Food and Drug Administration had previously seized counterfeit Ozempic drugs in 2023 and warned the public. This matter is significant for investors in Novo (NVO), as counterfeit drugs could harm the company's reputation and sales of its legitimate products.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News

Fintech Ramp Seeks OCC Trust Bank Charter to Expand Asset Services
Oct 19

Daily Loan Offers Raise Concerns Over Potential Scams
Oct 19

Nestle, Unilever Face Regulatory Action in India for Health Claims
Oct 18

China Plans Export Controls on Solar Tech to Safeguard Industry
Oct 18